Favorite Annette F: insider trades.
Favorite Annette F reported 12 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 6 sales ($5.4M), across 1 company.
- Transactions
- 12
- Purchases (P)
- 0
- Sales (S)
- 6
- Companies
- 1
- Name as filed
- Favorite Annette F
Companies
| Company | Relationship | Transactions |
|---|---|---|
| West Pharmaceutical Services Inc (WST) | Officer · Sr. VP & Chief HR Officer | 12 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-15 | West Pharmaceutical Services Inc | S | 2,524 | $365 | 21,818 | Form 4 |
| 2026-09-15 | West Pharmaceutical Services Inc | M | 2,524 | $89.64 | 24,342 | Form 4 |
| 2026-09-14 | West Pharmaceutical Services Inc | M | 2,500 | $89.64 | 24,318 | Form 4 |
| 2026-09-14 | West Pharmaceutical Services Inc | S | 2,500 | $355 | 21,818 | Form 4 |
| 2026-09-11 | West Pharmaceutical Services Inc | M | 2,500 | $89.64 | 24,318 | Form 4 |
| 2026-09-11 | West Pharmaceutical Services Inc | S | 2,500 | $345 | 21,818 | Form 4 |
| 2026-09-08 | West Pharmaceutical Services Inc | S | 2,818 | $340.81 | 16,845 | Form 4 |
| 2026-09-08 | West Pharmaceutical Services Inc | S | 2,500 | $340.81 | 16,845 | Form 4 |
| 2026-09-08 | West Pharmaceutical Services Inc | M | 2,500 | $89.64 | 19,345 | Form 4 |
| 2026-09-08 | West Pharmaceutical Services Inc | M | 2,817 | $83.47 | 19,662 | Form 4 |
| 2026-09-08 | West Pharmaceutical Services Inc | S | 2,817 | $340.81 | 16,845 | Form 4 |
| 2026-09-08 | West Pharmaceutical Services Inc | M | 2,818 | $83.47 | 19,663 | Form 4 |
Questions
What stock did Favorite Annette F buy or sell?
Favorite Annette F reported 12 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 6 sales ($5.4M), across 1 company.
Is Favorite Annette F the same person as other filers with this name?
This page covers SEC CIK 1654975 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/favorite-annette-f-1654975.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.